The added demand for testing and the higher prevalence of breakthrough cases have created an “opportune moment” to exploit.
This entry was posted
on Tuesday, January 11th, 2022 at 7:12 am and is filed under Technology.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.